|
End-of-day quote
Taiwan S.E.
20/11/2026
|
5-day change | 1st Jan Change | ||
| 38.30 TWD | -6.70% |
|
-16.28% | -35.41% |
Company Valuation: Formosa Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 5,085 | 7,275 | 8,839 | 12,266 | 8,274 | 7,131 |
| Change | - | 43.07% | 21.49% | 38.78% | -32.55% | -13.81% |
| Enterprise Value (EV) 1 | 8,446 | 9,602 | 11,008 | 13,819 | 9,470 | 8,247 |
| Change | - | 13.69% | 14.64% | 25.53% | -31.47% | -12.91% |
| P/E | 13.6x | 5.86x | 21.7x | 97.2x | 52.9x | 16.3x |
| PBR | 0.98x | 0.98x | 1.18x | 1.62x | 1.08x | 0.92x |
| PEG | - | 0x | -0.3x | -1.4x | 2.2x | 0x |
| Capitalization / Revenue | 1.65x | 2.32x | 2.35x | 2.81x | 1.75x | 1.47x |
| EV / Revenue | 2.75x | 3.06x | 2.92x | 3.17x | 2x | 1.7x |
| EV / EBITDA | 18.1x | 32.4x | 17.6x | 12.3x | 7.73x | 6.14x |
| EV / EBIT | 302x | -57.2x | 67.3x | 20.5x | 13x | 10.3x |
| EV / FCF | -11.8x | -56.1x | 47x | 37.1x | -128x | 20x |
| FCF Yield | -8.46% | -1.78% | 2.13% | 2.69% | -0.78% | 4.99% |
| Dividend per Share 2 | - | 2 | 1 | 2 | 3 | 3 |
| Rate of return | - | 3.31% | 1.36% | 1.96% | 4.36% | 5.06% |
| EPS 2 | 3.459 | 10.32 | 3.39 | 1.05 | 1.3 | 3.64 |
| Distribution rate | - | 19.4% | 29.5% | 191% | 231% | 82.4% |
| Net sales 1 | 3,075 | 3,142 | 3,766 | 4,360 | 4,731 | 4,851 |
| EBITDA 1 | 467.6 | 296.6 | 623.8 | 1,127 | 1,225 | 1,344 |
| EBIT 1 | 28.01 | -168 | 163.5 | 675 | 725.9 | 803.2 |
| Net income 1 | 400 | 1,249 | 409.4 | 126.2 | 157.3 | 441.1 |
| Net Debt 1 | 3,361 | 2,327 | 2,169 | 1,553 | 1,196 | 1,115 |
| Reference price 2 | 46.95 | 60.50 | 73.50 | 102.00 | 68.80 | 59.30 |
| Nbr of stocks (in thousands) | 108,313 | 120,256 | 120,256 | 120,256 | 120,256 | 120,256 |
| Announcement Date | 8/3/21 | 11/3/22 | 15/3/23 | 12/3/24 | 13/3/25 | 13/3/26 |
1TWD in Million2TWD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 149M | ||
| 39.52x | 13.4x | 28.41x | 0.5% | 1,204B | ||
| 36.48x | 6.57x | 18.48x | 1.99% | 643B | ||
| 36.15x | 8.33x | 17.22x | 2.43% | 501B | ||
| 21.54x | 5.2x | 13.03x | 2.51% | 378B | ||
| 94.27x | 5.43x | 23.16x | 2.56% | 327B | ||
| 22.77x | 5.51x | 13.41x | 2.89% | 285B | ||
| 22.87x | 4.6x | 13.08x | 1.92% | 270B | ||
| 22.66x | 7.01x | 12.88x | 2.3% | 237B | ||
| -39.16x | 7.25x | 45.68x | 1.98% | 207B | ||
| Average | 28.57x | 7.03x | 20.59x | 2.12% | 405B | |
| Weighted average by Cap. | 34.08x | 8.45x | 21.48x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 4746 Stock
- Valuation Formosa Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















